Critical illness – Treatment

Go back

Critical illness represents a life-threatening medical emergency that requires immediate, specialized care in an intensive care unit (ICU). When a person experiences such a severe health crisis—whether from sepsis, respiratory failure, heart attack, or major trauma—treatment becomes a complex process involving multiple medical interventions, constant monitoring, and a dedicated healthcare team working around the clock to preserve life and prevent complications.

When the Body Faces Its Greatest Challenge

Critical illness is not a single disease but rather a state where the body’s vital systems are failing or at imminent risk of failure. This condition demands urgent medical intervention beyond what standard hospital care can provide. People experiencing critical illness may have suffered severe burns, major strokes, kidney failure, septic shock, or serious injuries from accidents. They might be recovering from complex surgeries or battling respiratory failure that prevents them from breathing on their own.[11][14]

The primary goals of treating critical illness center on stabilizing the patient’s condition, supporting failing organ systems, preventing further deterioration, and addressing the underlying cause of the crisis. Treatment focuses on keeping patients alive while their bodies attempt to heal, which often means substituting for functions that vital organs can no longer perform independently. The approach to care depends heavily on which systems are failing, how severe the illness is, and the patient’s overall health before the crisis occurred.[10]

Every year, millions of people worldwide require critical care services. The intensive care environment differs dramatically from regular hospital wards because patients need continuous surveillance and immediate responses to any changes in their condition. A specialized team—including intensivists, nurses trained in critical care, respiratory therapists, pharmacists, and other healthcare professionals—provides this around-the-clock attention. Modern critical care combines established medical treatments approved by professional societies with ongoing research into innovative therapies being tested in clinical trials.[10][15]

Standard Treatment Approaches in Critical Care

The foundation of critical illness treatment involves life support, which means using medical equipment and interventions to maintain vital body functions. When patients cannot breathe adequately on their own, healthcare providers use mechanical ventilation—a breathing machine that moves air in and out of the lungs through a tube placed either through the mouth or through a surgically created opening in the neck called a tracheostomy. Ventilators are calibrated to deliver precise amounts of oxygen and to remove carbon dioxide, essentially taking over the work of breathing while the patient’s lungs recover. However, prolonged ventilation carries risks, including ventilator-associated pneumonia and lung injury, which is why medical teams work to reduce ventilator time whenever safely possible.[10][14]

For patients whose kidneys have failed, dialysis becomes necessary. These “artificial kidney” machines filter waste products and excess fluid from the blood, performing the essential cleaning function that healthy kidneys normally handle. Dialysis in critical care settings often occurs daily or even continuously, as critically ill patients accumulate toxins and fluid more rapidly than those with chronic kidney disease receiving outpatient dialysis.[11][14]

Maintaining adequate nutrition presents another critical challenge. Many critically ill patients cannot eat normally, so healthcare teams provide nutrition through feeding tubes inserted through the nose into the stomach or directly into the intestines. When the digestive system cannot function, patients receive nutrition intravenously, with specially formulated solutions delivering calories, proteins, vitamins, and minerals directly into the bloodstream. The type and amount of nutritional support is carefully calculated based on the patient’s condition, weight, and metabolic needs.[10]

Critical care commonly employs various types of catheters—flexible tubes used to deliver medications and fluids or to drain bodily fluids. Intravenous (IV) lines allow continuous delivery of fluids, antibiotics, sedatives, and other medications. Central venous catheters, which are larger IV lines placed in major veins near the heart, enable delivery of medications that would damage smaller veins and allow measurement of pressures within the heart and circulation. Arterial catheters placed in arteries provide continuous blood pressure monitoring and easy access for blood sampling. Urinary catheters drain urine from the bladder, allowing precise measurement of urine output, which helps assess kidney function and fluid balance.[10][14]

⚠️ Important
While these devices can save lives, they also increase infection risk. Each catheter, tube, or invasive device creates a potential entry point for bacteria. Healthcare teams follow strict sterile procedures during insertion and maintenance, but infections remain a significant concern in intensive care. This is why medical staff work to remove these devices as soon as they are no longer absolutely necessary.

Continuous monitoring forms another cornerstone of standard critical care. Electronic monitors track heart rate, blood pressure, breathing rate, oxygen levels in the blood, and other vital signs every second. These machines display information on screens at the bedside and at central nursing stations, with alarms alerting staff to dangerous changes. This constant surveillance allows immediate response to deterioration that might otherwise go unnoticed until it becomes life-threatening.[10][14]

Medication management in critical illness differs substantially from standard hospital care. Patients often receive multiple drugs simultaneously, including antibiotics to fight infections, sedatives to keep them comfortable while on ventilators, medications to support blood pressure and heart function, drugs to prevent blood clots, and medications to control pain. These drugs are frequently administered as continuous infusions rather than intermittent doses, allowing precise control of drug levels in the bloodstream. Pharmacists specializing in critical care help optimize these complex medication regimens and watch for dangerous drug interactions.[10]

The treatment of sepsis—a life-threatening response to infection where the body’s own immune reaction damages tissues and organs—follows specific protocols developed through extensive research. Treatment begins with rapid administration of broad-spectrum antibiotics, which are drugs effective against many types of bacteria. Healthcare providers also give large volumes of intravenous fluids to maintain blood pressure and deliver medications that constrict blood vessels if fluid alone cannot keep blood pressure adequate. Source control—finding and eliminating the infection source, whether by draining abscesses, removing infected tissues, or other surgical interventions—is critical for recovery.[11]

For patients who have suffered strokes or traumatic brain injuries, controlling pressure inside the skull becomes paramount. Elevated intracranial pressure can cause further brain damage or death. Treatment may include medications to reduce brain swelling, careful control of carbon dioxide levels through ventilator adjustments, positioning the head in specific ways to improve drainage of fluid from the brain, and sometimes surgical procedures to remove damaged tissue or create openings that allow the brain to swell without being compressed.[11]

The duration of intensive care treatment varies enormously depending on the underlying condition and the patient’s response to treatment. Some people require only a few days in the ICU before transferring to regular hospital floors, while others need weeks or even months of critical care support. Throughout this time, healthcare teams continually reassess the treatment plan, adjusting medications, ventilator settings, and other interventions based on the patient’s changing condition.[10]

Complications That Arise During Critical Care

Being critically ill places enormous stress on the body, and the treatments needed to sustain life can themselves cause complications. One of the most significant problems is critical illness weakness, also called critical illness myopathy (CIM) or critical illness polyneuropathy (CIP). This condition involves severe muscle weakness that develops during the ICU stay, affecting the limbs, trunk, and respiratory muscles. Patients may become unable to breathe without the ventilator, move their arms or legs, or even lift their heads. The weakness results from a combination of factors including the inflammatory processes occurring during severe illness, prolonged immobility, certain medications (particularly when corticosteroids and neuromuscular blocking agents are used together), poor nutrition, and metabolic disturbances.[12][13]

Critical illness myopathy specifically affects the muscles themselves, causing loss of the thick protein filaments (myosin) that enable muscle contraction. Type II muscle fibers, which are responsible for quick, powerful movements, atrophy dramatically. In critical illness polyneuropathy, the nerves controlling the muscles undergo axonal degeneration, meaning the long extensions of nerve cells that transmit signals deteriorate. Often, both conditions occur together, creating profound weakness that can persist for months or even years after discharge from the ICU.[12][16]

Risk factors for developing these neuromuscular complications include the severity of the initial illness (measured by scoring systems like the APACHE III), the presence of sepsis, multiple organ failures, high blood sugar levels, low blood albumin (a protein), prolonged bed rest, and possibly the use of certain medications. Female patients may be at higher risk than males. The weakness often becomes apparent when medical teams try to wean patients from the ventilator and discover they cannot breathe independently, or when consciousness improves and profound limb weakness becomes evident.[17]

Diagnosis of critical illness weakness begins with clinical observation. When a patient with adequate cognitive function displays diffuse, symmetrical weakness, doctors conduct manual muscle testing at the bedside. For patients who remain unconscious or confused, or when weakness is severe and persistent, specialized tests become necessary. Electrophysiological studies measure how nerves conduct electrical signals and how muscles respond to stimulation, helping distinguish between nerve problems (polyneuropathy) and muscle problems (myopathy). In selected cases, doctors may perform a muscle biopsy, removing a small piece of muscle tissue for examination under a microscope to look for characteristic changes in muscle structure.[12][16]

Prevention strategies for critical illness weakness center on minimizing risk factors when possible and promoting early mobilization. Healthcare teams now recognize that getting patients moving—even while still on ventilators—can help preserve muscle function. This approach, part of the ICU Liberation initiative developed by the Society of Critical Care Medicine, emphasizes reducing sedation to the minimum necessary, routinely assessing patients for delirium (confusion), managing pain effectively, and beginning physical therapy as early as safely feasible. These practices aim to minimize the iatrogenic harm—injury caused by medical treatment—that can occur during necessary critical care.[10][12]

The bundle of interventions known as the ABCDEF bundle provides a framework for implementing these preventive measures. The components include: Assessing and managing pain; Both spontaneous awakening trials (reducing sedation) and spontaneous breathing trials (testing if patients can breathe on their own); Choice of appropriate sedation medications; Delirium assessment and management; Early mobility; and Family engagement in care. Studies have shown that hospitals implementing this bundle see reductions in the duration of mechanical ventilation, ICU length of stay, and the incidence of delirium.[10]

Once critical illness weakness develops, treatment remains largely supportive. There are no specific medications proven to reverse the condition in humans. Rehabilitation becomes the cornerstone of recovery, involving intensive physical therapy to rebuild muscle strength, occupational therapy to regain the ability to perform daily activities, and sometimes speech therapy for patients with swallowing difficulties or weakness affecting speech. Recovery can be slow and frustrating, requiring months of dedicated effort. Some patients regain full function, while others experience permanent disability.[12][17]

Treatment Approaches Being Tested in Clinical Trials

Researchers worldwide are investigating new treatments for critical illness and its complications through clinical trials. These studies test whether experimental medications, devices, or care strategies are safe and effective before they become part of standard medical practice. Clinical trials progress through distinct phases: Phase I studies primarily assess safety in small groups of people; Phase II trials examine whether the treatment shows promise of effectiveness while continuing to monitor safety; and Phase III trials compare the new treatment against current standard care in larger populations to determine if it provides meaningful benefit.[10]

For critical illness myopathy specifically, several pharmacological approaches have shown promise in animal models and are moving toward human trials. BGP-15 is an experimental drug that has demonstrated anti-inflammatory effects and the ability to reduce muscle wasting in laboratory studies. In animal models of critical illness, BGP-15 improved muscle function and increased survival rates. The medication appears to work by protecting muscle cells from damage caused by inflammation and metabolic stress, although the exact mechanisms are still being investigated.[16]

Another investigational treatment is vamorolone, a modified corticosteroid designed to retain anti-inflammatory benefits while reducing the muscle-damaging side effects associated with traditional steroids. In preclinical studies, vamorolone showed potential to prevent or reduce the severity of critical illness myopathy. The drug modulates inflammatory pathways that contribute to muscle breakdown during severe illness without causing the same degree of muscle wasting seen with conventional corticosteroids.[16]

Ruxolitinib, a drug already approved for certain blood disorders, is being studied for its potential to prevent critical illness myopathy. This medication inhibits specific enzymes (JAK kinases) involved in inflammatory signaling pathways. In experimental models, ruxolitinib reduced inflammation, prevented muscle wasting, improved muscle function, and enhanced survival during critical illness. The drug’s ability to target the inflammatory cascade that drives muscle damage makes it a promising candidate for human trials.[16]

⚠️ Important
While these experimental treatments show promise in laboratory studies, they have not yet been proven safe or effective in human patients. Clinical trials are necessary to determine whether the benefits seen in animal models translate to people with critical illness. Patients and families should understand that participating in clinical trials involves both potential benefits and risks, and that not all experimental treatments ultimately prove successful.

Beyond pharmacological interventions, researchers are testing innovative approaches to early diagnosis of critical illness complications. A new electrophysiological technique for measuring muscle excitability shows potential to detect critical illness myopathy earlier than current diagnostic methods allow. By identifying muscle dysfunction before it becomes clinically apparent, this technique might enable earlier intervention that could prevent or minimize severe weakness. Early detection would also facilitate research studies by allowing investigators to test preventive treatments before substantial muscle damage has occurred.[16]

Clinical trials examining optimal nutritional support strategies continue to refine recommendations for feeding critically ill patients. Studies investigate questions such as when to begin feeding, how much protein to provide, whether certain nutritional supplements offer benefits, and whether the route of feeding (through tubes into the digestive system versus intravenously) affects outcomes. These trials aim to identify nutritional approaches that support recovery while minimizing complications like aspiration (breathing in stomach contents), high blood sugar, and feeding-related infections.[10]

Participation in clinical trials typically requires meeting specific eligibility criteria related to the type and severity of illness, age, and other factors. Trials may be conducted at specialized research centers in various countries including the United States, Europe, and other regions worldwide. Patients enrolled in trials receive careful monitoring and follow-up, with all treatments provided according to detailed protocols designed to ensure patient safety. Researchers must obtain informed consent, explaining all risks and benefits to patients or their designated decision-makers before enrollment.[10]

Most Common Treatment Methods

  • Mechanical Ventilation and Respiratory Support
    • Breathing machines (ventilators) that move air in and out of the lungs through a tube placed through the mouth or neck
    • Tracheostomy tubes surgically placed through the front of the neck into the windpipe for prolonged ventilation
    • Oxygen therapy to supplement breathing and maintain adequate blood oxygen levels
    • Adjustments to ventilator settings based on blood gas measurements and patient needs
  • Renal Replacement Therapy
    • Dialysis machines that filter waste products and excess fluid from blood when kidneys fail
    • Continuous renal replacement therapy for critically ill patients unable to tolerate intermittent dialysis
    • Careful monitoring of fluid balance and electrolyte levels
  • Nutritional Support
    • Feeding tubes placed through the nose into the stomach or intestines to provide liquid nutrition
    • Intravenous nutrition (parenteral nutrition) when the digestive system cannot function
    • Specialized formulas calculated based on patient weight, condition, and metabolic needs
  • Vascular Access and Monitoring
    • Central venous catheters in large veins for medication delivery and pressure monitoring
    • Arterial catheters for continuous blood pressure monitoring and blood sampling
    • Intravenous lines for fluids and medication administration
    • Urinary catheters to monitor urine output and kidney function
  • Medication Management
    • Broad-spectrum antibiotics for treating or preventing infections
    • Sedatives to keep patients comfortable during ventilation
    • Vasopressor medications to maintain adequate blood pressure
    • Pain control medications administered through continuous infusions
    • Blood thinners to prevent dangerous clot formation
  • Early Mobilization and Rehabilitation
    • Physical therapy beginning as early as safely possible, even for ventilated patients
    • Progressive exercises to maintain muscle strength and prevent weakness
    • Occupational therapy to preserve functional abilities
    • Reduced sedation protocols to facilitate earlier activity
  • Continuous Monitoring
    • Electronic monitors tracking heart rate, blood pressure, breathing rate, and oxygen levels
    • Central displays allowing nursing staff to observe multiple patients simultaneously
    • Alarm systems alerting staff to dangerous changes in vital signs
  • Sepsis Treatment Protocols
    • Rapid administration of antibiotics within specific timeframes
    • Large volumes of intravenous fluids to maintain blood pressure
    • Vasopressor medications if fluids alone cannot stabilize blood pressure
    • Source control through surgery or procedures to eliminate infection sources

Recovery and Long-Term Outcomes

Surviving critical illness represents only the beginning of a longer journey toward recovery. Patients who leave the ICU often face a constellation of physical, cognitive, and psychological problems collectively termed post-intensive care syndrome (PICS). This syndrome reflects the profound impact that critical illness and intensive care treatment have on multiple aspects of health and functioning.[11][20]

Physical impairments after critical illness commonly include persistent weakness, fatigue, and reduced exercise capacity. Muscle mass lost during the ICU stay can take many months to regain, and some patients never fully recover their pre-illness strength. Respiratory muscle weakness may cause ongoing breathing difficulties, particularly with exertion. Some people require continued use of supplemental oxygen at home. Walking, climbing stairs, and performing basic self-care activities that were once effortless may become exhausting challenges requiring assistance.[12][20]

Cognitive problems frequently emerge after critical illness, affecting memory, attention, and the ability to process information quickly. Survivors may struggle to concentrate, forget recent conversations or events, have difficulty making decisions, or find that mental tasks require much more effort than before. These cognitive changes can interfere with returning to work, managing finances, or participating in previously enjoyed activities. The cognitive impacts appear related to factors including prolonged periods of low oxygen, inflammatory processes affecting the brain, delirium during the ICU stay, and the use of sedative medications.[20]

Mental health challenges represent another major component of post-intensive care syndrome. Many ICU survivors develop anxiety disorders, experiencing persistent worry, panic attacks, or avoidance of medical settings. Depression is common, with feelings of sadness, loss of interest in activities, and thoughts that recovery is hopeless. Some patients develop post-traumatic stress disorder (PTSD) related to frightening experiences during critical illness, including hallucinations or nightmares that occurred while sedated, feelings of being unable to breathe, or traumatic memories of painful procedures. Sleep disturbances frequently persist long after discharge.[20]

Follow-up care after critical illness ideally involves a multidisciplinary approach. Some hospitals have established specialized follow-up clinics for ICU survivors, providing coordinated assessment and treatment of post-intensive care syndrome. These clinics typically include physicians, nurses, physical therapists, occupational therapists, psychologists, and dietitians who work together to address the multiple dimensions of recovery. Assessments focus on activities of daily living, mood, functional mobility, and nutritional status, with referrals to appropriate specialists as needed.[10][20]

Rehabilitation remains the cornerstone of recovery from critical illness weakness. Physical therapy works to rebuild strength and endurance through progressively challenging exercises. Occupational therapy helps patients relearn how to perform daily activities like dressing, bathing, and preparing meals. Speech therapy assists with swallowing problems and communication difficulties. The intensity and duration of rehabilitation needed varies greatly among individuals, with some requiring months of intensive inpatient rehabilitation while others can progress with outpatient therapy.[12]

Nutritional support continues to be important during recovery. Many ICU survivors have poor appetite, weight loss, and muscle wasting that persist after discharge. Dietitians can provide guidance on calorie-dense foods, protein supplementation, and strategies to improve appetite. Some patients need continued tube feeding at home until they can meet their nutritional needs by mouth. Adequate nutrition is essential for rebuilding lost muscle mass and supporting the healing process.[10]

The timeline for recovery from critical illness varies enormously. Some people return to their previous level of function within weeks or months, while others continue to have significant impairments a year or more after their ICU stay. Factors influencing recovery include the severity and duration of critical illness, the patient’s age and health before becoming ill, the development of complications like critical illness weakness, and access to comprehensive rehabilitation services. Research continues to identify predictors of recovery and interventions that might improve long-term outcomes.[12][20]

Family members and caregivers also experience significant impacts from a loved one’s critical illness. They may develop their own psychological distress, including anxiety, depression, and PTSD symptoms. Financial strain from lost work time, medical bills, and ongoing care needs adds additional stress. Support resources for families, including counseling, peer support groups, and practical assistance with caregiving tasks, are important components of comprehensive critical care that extend beyond the patient alone.[21]

Ongoing Clinical Trials on Critical illness

  • Study of Epoetin Alfa for Critically Ill Patients with Traumatic Injury

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Finland France Germany Ireland Slovenia
  • Study on Fish Oil Emulsion for Preventing Atrial Fibrillation in High-Risk Cardiac Surgery Patients

    Recruiting

    1 1
    Investigated diseases:
    Germany
  • Study on the Effectiveness and Safety of Extended vs. Intermittent Infusion of Meropenem in Critically Ill Children with Suspected or Proven Infection

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Hungary
  • Study on Midazolam Hydrochloride: Comparing Subcutaneous and Intravenous Use in Adults with Terminal Illness in Palliative Care

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway
  • Study on the Effects of Antibiotic Monitoring in ICU Patients Using Meropenem and Drug Combination

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Spain
  • Study on Hydrocortisone and Fludrocortisone for Adults with Critical Illness-Related Corticosteroid Insufficiency

    Not recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on Vancomycin Hydrochloride for Treating Serious Infections in Critically Ill Adults Using a Precision Dosing Tool

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Estonia

References

https://www.anthem.com/individual-and-family/insurance-basics/supplemental-limited-duration-insurance/critical-illness

https://www.metlife.com/stories/accident-health/what-is-critical-illness-insurance/

https://www.uhone.com/health-insurance/supplemental/critical-illness-insurance

https://www.unum.com/employees/benefits/critical-illness-insurance

https://www.voya.com/blog/what-critical-illness-insurance-and-how-can-it-help-you

https://www.aflac.com/resources/critical-illness-insurance/what-does-critical-illness-insurance-cover.aspx

https://en.wikipedia.org/wiki/Critical_illness_insurance

https://www.uhc.com/dental-vision-supplemental-plans/critical-illness-insurance

https://www.legalandgeneral.com/insurance/life-insurance/critical-illness-cover/critical-illness-whats-covered/

https://pmc.ncbi.nlm.nih.gov/articles/PMC9718009/

https://www.mayoclinic.org/departments-centers/critical-care/sections/conditions-treated/orc-20399557

https://ccforum.biomedcentral.com/articles/10.1186/s13054-023-04676-3

https://now.aapmr.org/critical-illness-myopathy/

https://medlineplus.gov/criticalcare.html

https://www.sccm.org/

https://pmc.ncbi.nlm.nih.gov/articles/PMC8958813/

https://ugeskriftet.dk/dmj/treatment-critical-illness-polyneuropathy-and-or-myopathy-systematic-review

https://www.securian.com/insights-tools/articles/coping-with-a-critical-illness.html

https://www.helpguide.org/wellness/health-conditions/coping-with-a-life-threatening-illness

https://www.ficm.ac.uk/criticalfutures/life-after-critical-illness

https://healthtalk.unchealthcare.org/7-ways-to-cope-with-a-loved-ones-serious-illness-or-injury/

https://www.aflac.com/resources/critical-illness-insurance/default.aspx

https://www.uhone.com/health-and-wellness/supplemental-insurance/5-things-you-should-know-about-critical-illness-insurance

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

What exactly is a critical illness?

Critical illness is a state where vital body systems are failing or at risk of failure, requiring immediate specialized care in an intensive care unit (ICU). It includes conditions like respiratory failure, septic shock, heart attack, stroke, kidney failure, severe burns, and major trauma. These conditions threaten life and require constant monitoring and support from specialized equipment and healthcare teams.

Why do patients develop severe weakness during ICU treatment?

Critical illness weakness develops from multiple factors including the inflammatory processes during severe illness, prolonged bed rest, certain medications (especially steroids combined with neuromuscular blocking agents), poor nutrition, metabolic disturbances, and high blood sugar levels. The condition affects both muscles (myopathy) and nerves (polyneuropathy), causing profound weakness that can persist for months after ICU discharge.

How long does recovery from critical illness typically take?

Recovery timelines vary enormously depending on the severity of illness, patient age, pre-existing health conditions, and complications that develop. Some people recover within weeks to months, while others continue experiencing significant physical, cognitive, and psychological impairments a year or more after their ICU stay. Complete recovery is not guaranteed, and some patients experience permanent disabilities.

What is the ABCDEF bundle in critical care?

The ABCDEF bundle is a framework developed by the Society of Critical Care Medicine to minimize harm during intensive care. It includes: Assessing and managing pain; Both spontaneous awakening and breathing trials; Choice of appropriate sedation; Delirium assessment and management; Early mobility; and Family engagement. Implementing this bundle reduces mechanical ventilation duration, ICU stays, and delirium rates.

Are there any new treatments being developed for critical illness complications?

Yes, several experimental drugs are being studied for critical illness myopathy. BGP-15, vamorolone, and ruxolitinib have shown promise in animal studies by reducing inflammation, preventing muscle wasting, and improving muscle function. However, these treatments have not yet been proven safe or effective in human patients and require clinical trials before becoming available as standard treatments.

🎯 Key Takeaways

  • Critical illness requires specialized ICU care with 24-hour monitoring and life support equipment like ventilators, dialysis machines, and multiple catheters for medication delivery.
  • Diagnostic tests influence 70% of healthcare decisions yet receive only 3-5% of healthcare budgets, highlighting the underappreciated importance of diagnostics in critical care.
  • Critical illness weakness affects both muscles and nerves, potentially causing profound disability that persists long after ICU discharge and may never fully resolve.
  • Early mobilization during ICU treatment, even while on a ventilator, can help prevent severe weakness and improve long-term outcomes.
  • Post-intensive care syndrome encompasses physical weakness, cognitive impairments, and mental health problems like anxiety, depression, and PTSD that affect many ICU survivors.
  • Experimental treatments like BGP-15, vamorolone, and ruxolitinib show promise for preventing muscle wasting in animal studies but require human trials before clinical use.
  • Just one week of bed rest can reduce muscle mass by 30%, with the steepest losses occurring in the first 2-3 weeks of ICU treatment.
  • Follow-up clinics for ICU survivors provide multidisciplinary care addressing physical, cognitive, and psychological recovery needs through coordinated specialist involvement.